By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Head Office
Technologielaan 3
Leuven    B - 3001  Belgium
Phone: 32-16-39-60-60 Fax: 32-16-39-60-70



Company News
Takeda (TKPYY) And TiGenix Report New Data Highlighting Maintenance Of Long-Term Remission Of Complex Perianal Fistulas In Crohn’s Disease Patients With Cx601 2/17/2017 6:39:00 AM
TiGenix Announces Acceptance Of Cx601 Abstract For Oral Presentation At 12th Congress Of ECCO 2/6/2017 8:38:55 AM
TiGenix Enrolls First Patient iIn Phase Ib/IIa Clinical Trial Of Cx611 In Severe Sepsis 1/31/2017 10:09:36 AM
Takeda (TKPYY) Notifies 4.48% Shareholding In TiGenix 1/9/2017 9:51:41 AM
TiGenix: Notice In Relation To The Convertible Bonds Due 2018 12/27/2016 9:48:32 AM
TiGenix Submits Day 120 Responses To EMA For Cx601 Marketing Authorization 12/27/2016 8:57:42 AM
Takeda (TKPYY) Makes €10 Million Equity Investment In TiGenix 12/21/2016 9:49:00 AM
TiGenix Announces Closing Of NASDAQ IPO 12/20/2016 10:48:25 AM
TiGenix Raises $35.65 Million Gross Proceeds With NASDAQ IPO 12/15/2016 9:41:38 AM
TiGenix Announces Launch Of Proposed Initial Public Offering In The United States 12/6/2016 10:18:46 AM